Evidence map›Paper›PMID 26294411›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2016

Analysis of Cell Proliferation and Homeostasis Using EdU Labeling.

Francis A Flomerfelt, Ronald E Gress

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. AnBiofabrication · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Ethylene-independent modulation of root development by ACC via downregulation of WOX5 and group I CLE peptide expression.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Francis A FlomerfeltExperimental Transplantation and Immunology Branch, National Cancer Institute, Building 10, CRC, Room 3-3330, Bethesda, MD, 20892, USA, flomerff@mail.nih.gov.
Ronald E Gress
National Cancer Institute · US

Funding

Immune ReconstitutionZIABC010525 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GRESS, RONALD · 2009 to 2023
$21.9M
Regulation of Transplantation ResponsesZ01BC010254 · BC · BASIC SCIENCES · PI GRESS, RONALD · 1996 to 2003
–
Intramural NIH HHS Z01 BC010254
6 · The paper itself

Abstract

Determination of cellular proliferation and population turnover is an important tool for research on lymphoid cell function. Historically this has been done using radiolabeled nucleotides or nucleoside analogs, such as BrdU (5-bromo-2-deoxyuridine), that are incorporated into nascent DNA during S-phase. Recently, a new procedure was developed to label nascent DNA using EdU (5-Ethynyl-2-deoxyuridine). This new method overcomes limitations imposed by the procedure used to detect BrdU because EdU detection is based on an easily performed chemical reaction that does not require DNA denaturation, is quick and reproducible, and has a superior signal-to-noise ratio. This technique offers a wide range of opportunities to analyze cellular proliferation, population homeostasis, and cell marking procedures.

Indexed as

Cell ProliferationHomeostasisBiomarkersBromodeoxyuridineDeoxyuridineDNA ReplicationFlow CytometryS PhaseStaining and Labeling5-ethynyl-2'-deoxyuridineBiomarkersBromodeoxyuridineDeoxyuridine

Identifiers

PMID26294411
PMCPMC7490834
OpenAlexW2410841132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.